NCT00717379

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

Open-Label, Randomized, Multicenter, Parallel-Group Efficacy and Safety Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To compare the efficacy and safety of Tacrolimus in combination with MMF and Steroids in two regimens of steroid in an adult kidney transplanted population.

Conditions

• Kidney Transplantation
• Kidney Failure, Chronic
• Renal Insufficiency, Chronic

Interventions

Type	Name	Description
DRUG	Tacrolimus	oral
DRUG	Mycophenolate Mofetil	oral
DRUG	Methylprednisolone or equivalent	oral
DRUG	Prednisone	oral

Timeline

• Start date: 2007-05-01
• Primary completion: 2008-10-01
• Completion: 2008-10-01
• First posted: 2008-07-17
• Last updated: 2009-04-15

Locations

6 sites across 1 country: Russia